These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 489038)

  • 21. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum magnesium in hepatic disorders.
    Misra NP; Fatima N
    J Indian Med Assoc; 1974 Aug; 63(4):119-22. PubMed ID: 4436564
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum lipids and lipoproteins in chronic liver disease.
    Fehér J; Romics L; Jakab L; Fehér E; Szilvási I; Papp G
    Acta Med Acad Sci Hung; 1976; 33(3):217-23. PubMed ID: 1031549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum magnesium levels in Indian childhood cirrhosis.
    Sharma A; Dhatt PS; Singh H; Gupta HL
    Indian Pediatr; 1975 Feb; 12(2):161-3. PubMed ID: 1158473
    [No Abstract]   [Full Text] [Related]  

  • 25. Magnesium deficiency in liver cirrhosis.
    Lim P; Jacob E
    Q J Med; 1972 Jul; 41(163):291-300. PubMed ID: 5072054
    [No Abstract]   [Full Text] [Related]  

  • 26. Study of serum and cerebrospinal fluid magnesium levels in cerebrovascular accidents.
    Dubey SN; Mehta RS
    Neurol India; 1975 Mar; 23(1):17-22. PubMed ID: 1143610
    [No Abstract]   [Full Text] [Related]  

  • 27. Role and metabolism of high density lipoprotein subfractions--analysis of serum HDL2-cholesterol and HDL3-cholesterol in patients with various diseases by high performance liquid chromatography.
    Tanaka A
    Bull Tokyo Med Dent Univ; 1982 Dec; 29(4):131-7. PubMed ID: 6959738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary gastrin output and serum gastrin in patients with liver cirrhosis. Urinary gastrin output in cirrhosis.
    Avgerinos A; Dimitriou-Voudri Y; Adamopoulos A; Papadimitriou N; Voudris B; Rekoumis G; Raptis S
    Hepatogastroenterology; 1994 Oct; 41(5):445-8. PubMed ID: 7851853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The cholesterol ester composition in the serum in alcoholics and in Zieve's syndrome].
    Knüchel F
    Med Welt; 1968 Feb; 6():367-70 passim. PubMed ID: 5713885
    [No Abstract]   [Full Text] [Related]  

  • 30. [Value of certain indicators of lipid metabolism in the diagnosis of liver cirrhosis].
    Bychkova VI; Botchenko EI
    Vrach Delo; 1974 Jan; (1):55-61. PubMed ID: 4468582
    [No Abstract]   [Full Text] [Related]  

  • 31. Intestinal zinc absorption in cirrhotic patients.
    Solis-Herruzo J; De Cuenca B; Muñoz-Rivero MC
    Z Gastroenterol; 1989 Jun; 27(6):335-8. PubMed ID: 2773530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lipid profile of liver cirrrhosis.
    Divate UP; Mutalik GS; Deshmukh PY; More KN; Sainani GS
    J Assoc Physicians India; 1977 May; 25(5):331-5. PubMed ID: 914766
    [No Abstract]   [Full Text] [Related]  

  • 33. Variable response of serum magnesium and total cholesterol to different magnesium intakes and exercise levels in rats.
    Brilla LR; Lombardi VP
    Magnesium; 1987; 6(4):205-11. PubMed ID: 3669730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in the lipid profile in chronic hepatopathies].
    Perales J; Angel Lasunción M; Cano A; Martín-Scapa MA; Matíes M; Herrera E
    Med Clin (Barc); 1994 Mar; 102(10):364-8. PubMed ID: 8182981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can dietary magnesium modulate lipoprotein metabolism?
    Singh RB; Rastogi SS; Sharma VK; Saharia RB; Kulshretha SK
    Magnes Trace Elem; 1990; 9(5):255-64. PubMed ID: 2130823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
    Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
    Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum neopterin levels in liver cirrhosis.
    Antoniello S; Russo M; Bizzarro A; Auletta M; De Bellis A; Magri P; Russo P; Dell'Aquila A; Cacciatore L
    J Biol Regul Homeost Agents; 1989; 3(4):159-62. PubMed ID: 2638148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered insulin receptor processing and membrane lipid composition in erythrocytes of cirrhotic patients.
    Peterson SW; Angelico M; Masella R; Foster K; Gandin C; Cantafora A
    Ital J Gastroenterol; 1992 Feb; 24(2):65-71. PubMed ID: 1576365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of serum anion gap in patients with liver cirrhosis of diverse etiologies.
    Hassan H; Joh JH; Bacon BR; Bastani B
    Mt Sinai J Med; 2004 Sep; 71(4):281-4. PubMed ID: 15365595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Shurberg JL; Resnick RH; Koff RS; Ros E; Baum RA; Pallotta JA
    Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.